Inclusion Criteria : 
  -  1.  Patient with paroxysmal atrial fibrillation who is scheduled for ablation procedure and ≥ 20 and ≤ 80 years of age
  -  2.  Left atrium size < 45 mm
  -  3.  paroxysmal atrial fibrillation that is recurrence during antiarrhythmic drug treatment or is not able to use an antiarrhythmic drug . 
  -  4.  Patient who is indicated for anticoagulation therapy ( for prevention of cerebral infarction ) 
Exclusion Criteria : 
  -  1.  Patients with persistent or permanent atrial fibrillation
  -  2.  Atrial fibrillation associated with severe cardiac malformation or a structural heart disease that is hemodynamically affected
  -  3.  Patients with severe renal impairment or CT imaging difficulty using contrast media
  -  4.  Patients with a past history of radiofrequency ablation for atrial fibrillation or other cardiac surgery
  -  5.  Patients with active internal bleeding
  -  6.  Patients with contraindications for anticoagulation therapy ( for prevention of cerebral infarction ) and antiarrhythmic drugs
  -  7.  Patients with valvular atrial fibrillation ( mitral stenosis > grade 2 , mechanical valve , mitral valvuloplasty ) 
  -  8.  Patients with a severe comorbid disease
  -  9.  Expected survival < 1 year
  -  10.  Drug addicts or alcoholics
  -  11.  Patients who cannot read the consent form ( illiterates , foreigners , etc. ) 
  -  12.  Other patients who are judged by the principal or sub - investigator to be ineligible for participation in this clinical study